{{Drugbox
| IUPAC_name = 2,4,5,6-tetrahydro-9-methoxy-4-methyl-1''H''-3,4,6a-triazafluoranthene
| image = Metralindole structure.svg
| width = 100

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 53734-79-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 68713
| ChemSpiderID = 61964
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2QW3FL6OPA

<!--Chemical data-->
| C=15 | H=17 | N=3 | O=1 
| molecular_weight = 255.32 g/mol
| smiles = CN1CCN2C3=C(C=C(C=C3)OC)C4=C2C1=NCC4
}}

'''Metralindole''' ('''Inkazan''') is a [[reversible inhibitor of monoamine oxidase A]] (RIMA) which was investigated in [[Russia]] as a potential [[antidepressant]].<ref name="pmid1884793">{{cite journal | vauthors = Andreeva NI, Golovina SM, Faermark MF, Shvarts GI, Mashkovskiĭ MD | title = [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine] | language = Russian | journal = Farmakologiia I Toksikologiia | volume = 54 | issue = 2 | pages = 38–40 | year = 1991 | pmid = 1884793 | doi = | url = }}</ref>  It is [[chemical structure|structurally]] and [[pharmacology|pharmacologically]] related to [[pirlindole]].

== See also ==
* [[Pirlindole]]
* [[Tetrindole]]

== References ==
{{Reflist}}

{{Antidepressants}}
{{Anxiolytics}}
{{Monoamine metabolism modulators}}

[[Category:Antidepressants]]
[[Category:Monoamine oxidase inhibitors]]
[[Category:Russian drugs]]

{{nervous-system-drug-stub}}